Tag: DNA medicine

Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)

Retrospective trial showed Overall Response Rate (ORR) improved to 86% at the end of the second 12-month period (Year 2) compared to 72% observed...

INOVIO to Present at Upcoming Scientific Conference

PLYMOUTH MEETING, Pa., July 7, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and...

- A word from our sponsors -

HomeTagsDNA medicine

Huasun Ranked 12th on TIME’s World’s Top GreenTech Companies of 2026, Leaping 22 Places on the Strength of HJT Conviction

Scenic Biotech Joins Michael J. Fox Foundation’s LITE Program to Explore New Disease-Modifying Approach for Parkinson’s Disease

Zoetis Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – ZTS

Tag: DNA medicine

Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)

INOVIO to Present at Upcoming Scientific Conference

Explore

Press Releases

News & Opinion

Living

Others

Follow us